{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:42:17Z","timestamp":1770745337528,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccep.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:08:08Z","timestamp":1764047288000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Antiarrhythmic Drug Therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Farah","family":"Olleik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ccep.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.006_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ccep.2025.10.006_bib3","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"issue":"9019","key":"10.1016\/j.ccep.2025.10.006_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators. Survival with oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.006_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiology"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.006_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10557-020-07103-9","article-title":"Vernakalant for rapid cardioversion of recent-onset atrial fibrillation: results from the SPECTRUM study","volume":"35","author":"L\u00e9vy","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"13","key":"10.1016\/j.ccep.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-023-01923-3","article-title":"Recent advances in antiarrhythmic drug therapy","volume":"83","author":"Saljic","year":"2023","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.006_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ahj.2014.06.003","article-title":"Cardiac safety research consortium: can the thorough QT\/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward","volume":"168","author":"Darpo","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.5114\/amsad.2020.97103","article-title":"Implantable cardioverter defibrillators - the past, present and future","volume":"5","author":"Ammannaya","year":"2020","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pcad.2005.06.002","article-title":"Mechanisms of atrial fibrillation: lessons from animal models","volume":"48","author":"Nattel","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.006_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/imj.15976","article-title":"Contemporary updates on ventricular arrhythmias: from mechanisms to management","volume":"53","author":"Bhaskaran","year":"2023","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bjae.2022.11.001","article-title":"Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias","volume":"23","author":"Kim","year":"2023","journal-title":"BJA Educ"},{"issue":"20","key":"10.1016\/j.ccep.2025.10.006_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206094","article-title":"Amiodarone therapy: updated practical insights","volume":"13","author":"\u0218orodoc","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar Jos\u00e9","year":"2024","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"14","key":"10.1016\/j.ccep.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"issue":"25","key":"10.1016\/j.ccep.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccep.2025.10.006_bib18","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2024.38","article-title":"Arrhythmias and sudden death: what is new in hypertrophic cardiomyopathy?","volume":"11","author":"Rajan","year":"2025","journal-title":"Card Fail Rev"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.006_bib19","article-title":"Arrhythmias in patients with cardiac amyloidosis: a comprehensive review on clinical management and devices","volume":"10","author":"Briasoulis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/S2666-7568(22)00186-6","article-title":"Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England","volume":"3","author":"Tan","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12872-024-03983-z","article-title":"Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis","volume":"24","author":"Chander","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.006_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler","year":"2006","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"issue":"19","key":"10.1016\/j.ccep.2025.10.006_bib24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","article-title":"The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Camm","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2025.10.006_bib25","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2024.41","article-title":"From atrial small-conductance calcium-activated potassium channels to new antiarrhythmics","volume":"19","author":"Saljic","year":"2024","journal-title":"Eur Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ehjcvp\/pvy022","article-title":"A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation","volume":"5","author":"Camm","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clinthera.2023.01.014","article-title":"Effectiveness and safety profiles of vernakalant for cardioversion of acute-onset atrial fibrillation: a systematic review and meta-analysis","volume":"45","author":"Yu","year":"2023","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-023-02679-9","article-title":"Inhibition of the K(Ca)2 potassium channel in atrial fibrillation: a randomized phase 2 trial","volume":"30","author":"Holst","year":"2024","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.006_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacep.2024.02.021","article-title":"Orally inhaled flecainide for conversion of atrial fibrillation to sinus rhythm: INSTANT phase 2 trial","volume":"10","author":"Ruskin","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"issue":"10396","key":"10.1016\/j.ccep.2025.10.006_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(23)00776-6","article-title":"Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial","volume":"402","author":"Stambler","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.006_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtcvs.2015.06.061","article-title":"Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation","volume":"151","author":"Wang","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.006_bib32","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3390\/cimb46090571","article-title":"Recent advances in understanding the molecular mechanisms of SGLT2 inhibitors in atrial remodeling","volume":"46","author":"Minciun\u0103","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jacep.2023.06.008","article-title":"Impact of SGLT2 inhibitors on AF recurrence after catheter ablation in patients with type 2 diabetes","volume":"9","author":"Abu-Qaoud","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.006_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.repce.2020.11.024","article-title":"Update on the efficacy of statins in primary and secondary prevention of atrial fibrillation","volume":"40","author":"Oraii","year":"2021","journal-title":"Revista Portuguesa de Cardiologia (English Edition)"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.006_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008197","article-title":"Canakinumab after electrical cardioversion in patients with persistent atrial fibrillation: a pilot randomized trial","volume":"13","author":"Krisai","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca(2+)\/Calmodulin-Dependent Kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.006_bib37","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jcmg.2023.06.008","article-title":"Early observations on effects of mavacamten on left atrial function in obstructive hypertrophic cardiomyopathy patients","volume":"16","author":"Wessly","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ccep.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/CIRCULATIONAHA.123.066989","article-title":"Antiarrhythmic drug therapy: where do we go from here?","volume":"149","author":"Kowey","year":"2024","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.ccep.2025.10.006_bib39","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.006_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of \u03b2-Blockers, amiodarone plus \u03b2-Blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillatorsThe OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2025.10.006_bib41","first-page":"10","article-title":"Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials. Systematic review","author":"Chen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ccep.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2016.10.025","article-title":"Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: the SHIELD-2 trial","volume":"185","author":"Robinson","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2025.10.006_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1525836","article-title":"Effects of Eleclazine (GS6615) on the proarrhythmic electrophysiological changes induced by myocardial stretch","volume":"16","author":"Chorro","year":"2025","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.006_bib44","article-title":"Efficacy and limitations of quinidine in patients with Brugada syndrome","volume":"12","author":"Mazzanti","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.006_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells14020131","article-title":"CRISPR-Cas9 in cardiovascular medicine: unlocking new potential for treatment","volume":"14","author":"Bonowicz","year":"2025","journal-title":"Cells"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:44:42Z","timestamp":1770695082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918225000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1877918225000802"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.006","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Antiarrhythmic Drug Therapy","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}